Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: A perspective from the EBMT cell-processing committee
Publication date
2015-03-01
Authors
Chabannon, C.
Hildebrandt, M.
Scheding, S.
Humpe, A.
Lowdell, M.
Slaper-Cortenbach, Ineke
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Hematology, Transplantation, General Medicine, Editorial
Citation
Chabannon, C, Hildebrandt, M, Scheding, S, Humpe, A, Lowdell, M & Slaper-Cortenbach, I 2015, 'Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future : A perspective from the EBMT cell-processing committee', Bone Marrow Transplantation, vol. 50, no. 3, pp. 321-323. https://doi.org/10.1038/bmt.2014.271